HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI
In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants
L-PAM Benefit To Post-Menopausal Patients Challenged
NCI Relates FDA Instructions On Latest IND Delays
Two Workshops To Look For New Research Areas
Proposed Regulations for Center Grants In Federal Register
Obey Attacks NCI In Campaign Speech
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded









